Study of IBI308 With Advanced/Metastatic Esophageal Squamous Cell Carcinoma After Failure of First-line Treatment
Clinical trial NCT03116152 · COMPLETED
Trial details
- NCT number
- NCT03116152
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-10
- Primary completion
- 2019-10-02
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.